All you need is a smartphone, tablet, or computer to engage with one of our expert semaglutide providers
#GIhomeschooling ACGs Functional GI & Motility Disorders School & ACG/MIGI Midwest Regional Postgraduate Course Detroit, MI August 14-16, 2026 ACGs Obesity & Metabolic Disorders School & ACG/VGS/MASGNA Regional Postgraduate Course Williamsburg, VA August 28-30, 2026 GI Societies Oppose Proposed Federal Rule That Would Reshape Biomedical Research ACG opposes the recent OMB proposal to have political appointees approve all NIH research grants ACG Proudly Endorses the Patients First Act ACG is grateful to the GOP and Democratic Doctors Caucuses for introducing this crucial Medicare physician reimbursement bill Member Alert: Proposed 2027 Medicare Rules Would Cut GI Payments ACG is alarmed by CMS proposal for new efficiency cuts and changes to practice expense methodology Clinical and Translational Gastroenterology Clinical and Translational Gastroenterology is a peer-reviewed, open access online journal dedicated to innovative clinical work in the field of gastroenterology and hepatology
What to Expect (Phase by Phase) Weeks 13: Adjustment Mild water retention and bloating (GH effect settles by week 3-4) Morning joint stiffness or slight puffiness in hands (common, dose-related) Possible fatigue from stronger overnight GH pulses Some users notice improved sleep quality immediately Weeks 38: Building Phase Improved recovery between workouts becomes noticeable Gradual lean mass improvements this is not a fast-acting protocol Reduced body fat, particularly visceral fat with extended use Skin quality improvements (GH + IGF-1 effect on collagen) Increased hunger is common your metabolism is running higher Weeks 816: Full Effect Strength and endurance improvements compound Body composition changes become clearly visible Sleep quality, hair, and skin improvements often cited by long-term users Some users notice joint comfort improvements (IGF-1 has cartilage effects) Side Effects and How to Manage Them Water retention: Most common early on
Initially, it was approved for the treatment of type 2 diabetes, where it proved highly effective in improving blood sugar control
The analysis of Wegovy was limited by insufficient adverse event reports to draw statistical conclusions, precluding meaningful interpretation of risk patterns for this formulation
Raised patches of skin called plaques may also appear, along with visibly broken blood vessels
